[HTML][HTML] Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers

J Jin, Y Xie, JS Zhang, JQ Wang, SJ Dai, W He… - Drug Resistance …, 2023 - Elsevier
Currently, renal cell carcinoma (RCC) is the most prevalent type of kidney cancer. Targeted
therapy has replaced radiation therapy and chemotherapy as the main treatment option for …

Tutorial Review on the Set‐Up and Running of Quantum Mechanical Cluster Models for Enzymatic Reaction Mechanisms

SP de Visser, HPH Wong, Y Zhang… - … A European Journal, 2024 - Wiley Online Library
Enzymes turnover substrates into products with amazing efficiency and selectivity and as
such have great potential for use in biotechnology and pharmaceutical applications …

Insights into Cytochrome P450 Enzymes Catalyzed Defluorination of Aromatic Fluorides

Y Zhang, T Mokkawes - … Chemie International Edition, 2023 - research.manchester.ac.uk
The biodegradability of many fluorinated compounds is limited due to the robustness of the
C F bond. Recently, experimental studies suggested the potential involvement of …

A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment

J Lee, JL Beers, RM Geffert, KD Jackson - Biomolecules, 2024 - mdpi.com
Drug metabolism is a major determinant of drug concentrations in the body. Drug-drug
interactions (DDIs) caused by the co-administration of multiple drugs can lead to alteration in …

[HTML][HTML] Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review

IM Mokhosoev, DV Astakhov, AA Terentiev… - Cells, 2024 - mdpi.com
Background: Cytochromes P450 (CYPs) are heme-containing oxidoreductase enzymes with
mono-oxygenase activity. Human CYPs catalyze the oxidation of a great variety of …

Investigations on the electrochemical behavior of sunitinib and metabolites N-desethyl-sunitinib and sunitinib-N-oxide and its selective determination using …

F Budak, A Cetinkaya, SI Kaya, EB Atici, SA Ozkan - Electrochimica Acta, 2023 - Elsevier
Sunitinib (SUN) is an orally administered tyrosine kinase inhibitor and is mainly metabolized
via N-deethylation to form the primary active metabolite N-desethyl-sunitinib (M1) and via …

Metabolic transformation of cyclopiazonic acid in liver microsomes from different species based on UPLC-Q/TOF-MS

Y Ye, X Sun, C Huang, J Ji, J Sun, Y Zhang… - Journal of Hazardous …, 2024 - Elsevier
To investigate the metabolic transformation of cyclopiazonic acid (CPA) in the liver of
different species and to supplement accurate risk assessment information, the metabolism of …

Metabolic activation of tyrosine kinase inhibitors: recent advance and further clinical practice

M Yan, W Li, WB Li, Q Huang, J Li, HL Cai… - Drug Metabolism …, 2023 - Taylor & Francis
At present, receptor tyrosine kinase signaling-related pathways have been successfully
mediated to inhibit tumor proliferation and promote anti-angiogenesis effects for cancer …

Metabolism studies of 4′ Cl‐CUMYL‐PINACA, 4′ F‐CUMYL‐5F‐PINACA and 4′ F‐CUMYL‐5F‐PICA using human hepatocytes and LC‐QTOF‐MS analysis

D Stalberga, S Ingvarsson, G Bessa… - Basic & Clinical …, 2023 - Wiley Online Library
Abstract 4′ Cl‐cumyl‐PINACA (SGT‐157), 4′ F‐cumyl‐5F‐PINACA (4F‐cumyl‐5F‐
PINACA, SGT‐65) and 4′ F‐cumyl‐5F‐PICA (4F‐cumyl‐5F‐PICA, SGT‐64) are a series of …

[HTML][HTML] Strategy for Cysteine-Targeting Covalent Inhibitors Screening using In-house Database based LC-MS/MS and Drug Repurposing

X Hu, JL Wu, Q He, ZQ Xiong, N Li - Journal of Pharmaceutical Analysis, 2024 - Elsevier
Targeted covalent inhibitors, primarily targeting cysteine residues, have attracted great
attention as potential drug candidates due to good potency and prolonged duration of …